Opportunity timeline
In plain English
NIDDK is seeking industry collaborators to provide Phase I-tested therapeutics, diagnostic markers, biomarkers, or devices for NIH-sponsored clinical studies of childhood cholestatic liver diseases. Potential work includes clinical trials, infant screening, noninvasive imaging, and research into disease progression and treatment response. Interested organizations must submit a capability statement of no more than 10 pages, plus appendices.
About this opportunity
The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) Seeks Industry Partners for Clinical Research Collaborations on Therapeutics, Diagnostics or Devices for Childhood Cholestatic Liver Diseases The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) of the National Institutes of Health (NIH) of the Department of Health and Human Services (DHHS) seeks industry collaborators to provide novel therapeutic agents, diagnostic markers, biomarkers and devices for use in NIH-sponsored multi-center clinical trials and ancillary studies in patients with childhood cholestatic liver diseases, including biliary atresia, alpha-one antitrypsin deficiency,…
Standing opportunity — rolling deadline
Open long-term (listed until May 31, 2029). Check the posting for round or enrollment dates.
Related Opportunities

Illumina DRAGEN Tier 3 Throughput License and v4 Server

Emergent Drug Panel-Version 2 (EDP-V2) Kit

Medicinal Chemistry Support Program for Therapeutic Development (MCSP)

Medicinal Chemistry Support Program for Therapeutic Development (MCSP)

Health Advisory Committees Research and Support
Bid details are gathered and summarized automatically. Please verify details at the original source.
Ref No.
BS-4D3E6F

